Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Tiriac, Hervé, Belleau, Pascal, Engle, Dannielle D., Plenker, Dennis, Deschênes, Astrid, Somerville, Tim D. D., Froeling, Fieke E. M., Burkhart, Richard A. +62 more·2018·Cancer Discovery
DOI 10.1158/2159-8290.cd-18-0349

Cited by (1,001)

Items 701–800 of 1,001

  1. Predicting DNA damage response in non-small cell lung cancer organoids via simultaneous label-free autofluorescence multiharmonic microscopy
    Terrence T. Roh, Aneesh Alex, Prasanna Modayur Chandramouleeswaran, Janet Elise Sorrells, Alexander Ho, Rishyashring R. Iyer, Darold R. Spillman, Marina Marjanović, Jason E. Ekert, BanuPriya Sridharan et al. · 2024 · Redox Biology
  2. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
    Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, Marija Grozdanić, Ana Podolski-Renić, Milica Pešić · 2024 · Life
  3. Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study
    Ifigenia Vasiliadou, Christiana Cattaneo, Phoebe Yuen Ka Chan, Rhonda Henley‐Smith, Harry Gregson-Williams, Lisette Collins, Gabriella Wojewodka, Teresa Guerrero Urbano, Jean‐Pierre Jeannon, Steve E. J. Connor et al. · 2024 · BMJ Open
  4. Establishing a cryopreserved biobank of living tumor tissues for drug sensitivity testing
    Ping Chen, Jingbo Zhou, Xiangpeng Chu, Yangyang Feng, Qibing Zeng, Josh-Haipeng Lei, Ka-Pou Wong, Tai-Ip Chan, Chon-Wa Lam, Wenli Zhu et al. · 2024 · Bioactive Materials
  5. Preliminary study of utilizing a patient derived tumor spheroid model to augment precision therapy in metastatic brain tumors
    Chun-Jen Chang, Kai‐Wen Kan, Yu‐Yin Shih, Yu-Han Nan, Yu-Chung Juan, Chih-Hsiu Tu, Chen-Ting Yang, Wei-Lin Hsu, Der‐Yang Cho, Ming‐You Shie et al. · 2024 · Scientific Reports
  6. Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines
    A. V. Razumovskaya, M. O. Silkina, Andrey A. Poloznikov, Timur Kulagin, M. P. Raigorodskaya, N. A. Gorban, Anna V. Kudryavtseva, Maria Fedorova, B. Yа. Alekseev, Alexander Tonevitsky et al. · 2025 · Frontiers in Molecular Biosciences
  7. Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples
    Braelyn Binkowski, Zachary L. Klamer, ChongFeng Gao, Ben Staal, Anna Repesh, Hoang-Le Tran, David M. Brass, Pamela Bartlett, Steve Gallinger, Maria Blomqvist et al. · 2025 · Science Advances
  8. Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma
    Cristina Salmerón, Elena Tomás Bort, Krishna Sriram, Mehrak Javadi Paydar, Jane E. Smitham, Kimberly Pham, Richard Philip Grose, Peter James McCormick, Anna Di Nardo, Jonathan Weitz et al. · 2025 · Journal of Pharmacology and Experimental Therapeutics
  9. Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells
    Tadayoshi Yamaura, Hiroyuki Miyoshi, Hisatsugu Maekawa, Tomonori Morimoto, Takehito Yamamoto, Fumihiko Kakizaki, Koichiro Higasa, Kenji Kawada, Fumihiko Matsuda, Yoshiharu Sakai et al. · 2018 · Oncotarget
  10. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells
    Jin Niu, Xue Wang, Jun Qu, Donald E. Mager, Robert M. Straubinger · 2020 · BMC Cancer
  11. In vitro Modeling of Embryonal Tumors
    Lars Custers, Irene Paassen, Jarno Drost · 2021 · Frontiers in Cell and Developmental Biology
  12. Organoid models derived from patients with malignant phyllodes tumor of the breast
    Xinyu Chu, Ming‐Tsang Wu, Jianbo Yang, Yang Fu, Xuewei Wang, Huan Wang, Xiao Yang, Dong Chen, Jinsong He · 2023 · Breast Cancer Research and Treatment
  13. Modeling Liver Development and Disease in a Dish
    Waqas Iqbal, Yaru Wang, Pingnan Sun, Xiaoling Zhou · 2023 · International Journal of Molecular Sciences
  14. Modeling Epithelial Homeostasis and Perturbation in Three-Dimensional Human Esophageal Organoids
    Masataka Shimonosono, Masaki Morimoto, Wataru Hirose, Yasuto Tomita, Norihiro Matsuura, Samuel P. Flashner, Mesra S. Ebadi, Emilea H. Okayasu, Christian Y. Lee, William R. Britton et al. · 2024 · Biomolecules
  15. Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients
    Akihito Machinaga, Yuichi Hori, Kazuya Shimizu, K Okahara, Emmy Yanagita, Makoto Miyoshi, Tomoo Itoh, Ken Sasai · 2019 · Pancreas
  16. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
    Hervé Tiriac, Randall P. French, Andrew M. Lowy · 2020 · Journal of Visualized Experiments
  17. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
    Maria E. Monberg, Heather M. Geiger, Jaewon James Lee, Roshan Sharma, Alexander Semaan, Vincent Bernard, Justin Wong, Fang Wang, Shaoheng Liang, Daniel B. Swartzlander et al. · 2022 · RePEc: Research Papers in Economics
  18. Evolution of oncosurgical management of pancreatic cancer
    Ulla Klaiber, Susanne Roth, Thilo Hackert, John P. Neoptolemos · 2019 · European surgery. Supplement/European surgery
  19. Organoidomics — falling star or new galaxy in pancreatic cancer?
    Thomas Theodor Werner Seufferlein, Alexander Kleger · 2018 · Nature Reviews Gastroenterology & Hepatology
  20. Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers
    Ling Huang, Bruno Bockorny, Indranil Paul, Dipikaa Akshinthala, Omar Gandarilla, Arindam Bose, Veronica Sanchez‐Gonzalez, Emily E. Rouse, Sylvain D. Lehoux, Nicole Pandell et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Phenotypic, Genomic, and Transcriptomic Heterogeneity in a Pancreatic Cancer Cell Line
    Gengqiang Xie, Liting Zhang, Olalekan H. Usman, Sampath Kumar, Chaity Modak, Dhenu Patel, Megan Kavanaugh, Xian Mallory, Yue Julia Wang, Jerome Irianto · 2024 · Pancreas
  22. A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures
    Silvia Strocchi, Giacomo Santandrea, Eleonora Zanetti, Giulio Verna, Vincenza Ylenia Cusenza, Davide Nicoli, Valentina Fantini, A Grieco, Massimiliano Paci, Alessia Ciarrocchi et al. · 2024 · Cancers
  23. Bench to Bedside Modeling of mRNA Encoding IgG Using a Multiscale Mechanistic Pharmacokinetic‐Toxicokinetic ( PK ‐ TK ) Model: A Case Study With Anti‐Claudin 18.2
    Devam A Desai, Rodrigo Cristofoletti · 2025 · Clinical and Translational Science
  24. Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures
    Brice Chanez, Matthieu Delaye, Nicolas Alejandro Fraunhoffer, Juan Iovanna, Cindy Neuzillet, Nelson Dusetti · 2025 · United European Gastroenterology Journal
  25. Pancreatic Cancer Organoids Recapitulate Chemotherapy Response and Identify a Potent Cytotoxic T-Cell Population
    Renee R. Anderko, Alexandra E Bowman, Praneel Murthy, Pranav Murthy, Asmita Chopra, Nikhil V. Tirukkovalur, Sebastiaan Ceuppens, Alessandro Paniccia, Kenneth K.W. Lee, Robbie B. Mailliard et al. · 2025 · Clinical Cancer Research
  26. Longitudinal, label-free, high-resolution imaging of glioblastoma spheroid response to therapy: a translational tool for preclinical evaluation of chemotherapy, radiation, and immunotherapy
    Caroline E. Serafini, Amin Davarzani, Dan Cappabianca, Zhenmin Li, Daniela Baez Collazos, Deniz Mamaghani, Leidong Mao, Krishanu Saha, Lohitash Karumbaiah, Francisco E. Robles · 2025 · Optica
  27. Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling
    Kimiya Rashidan, Malaksima Ayadilord, Ali Hazrati, Amirhossein Nazerian, Abbas Shafiee, Seyed Mahmoud Hashemi · 2025 · MedComm
  28. Organoids in translation: a bench-to-bedside framework for pancreatic cancer precision medicine
    Danial A. Malik, E. Schmieder, Gina Genova, Jeremey Gaskins, Robert C.G. Martin · 2026 · Journal of Translational Medicine
  29. Patient-derived osteosarcoma tumoroid model reveals functional phenotypic diversity with implications for drug responses
    Sugandha Bhatia, Briony Claxton, Erik W. Thompson, Martin Lowe, Michael Wagels, Wayne Nicholls, Philip D. Rowell, Dietmar Werner Hutmacher, Jacqui McGovern · 2026 · Biofabrication
  30. Harnessing human tumor organoids for cancer modeling and precision therapy
    Tonghai Zhou, Qianyi Wang, Zhang Mei-li, Yue Huang · 2026 · Protein & Cell
  31. Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines
    Julia Krushkal, Suleyman Vural, Travis Lee Jensen, George W. Wright, Yingdong Zhao · 2022 · Clinical Epigenetics
  32. Progress in patient-derived liver cancer cell models: a step forward for precision medicine
    Zhengtao Zhang, Lijian Hui · 2023 · Acta Biochimica et Biophysica Sinica
  33. Establishment of matched bladder cancer PDX and PDX-derived organoid model and evaluation of anti-tumor efficacy of abemaciclib
    Xiongbing Lu, Chao Hu, Lingxing Duan, Ke Chen, Hua Hao, Yuanqiao He · 2024 · Clinical & Translational Oncology
  34. Quantitative Live Imaging Reveals Phase Dependency of PDAC Patient‐Derived Organoids on ERK and AMPK Activity
    Shoko Tsukamoto, Ye Huaze, Zhang Weisheng, Akihito Machinaga, Nobuyuki Kakiuchi, Seishi Ogawa, Hiroshi Seno, Shigeki Higashiyama, Michiyuki Matsuda, Toru Hiratsuka · 2024 · Cancer Science
  35. MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential
    Fangying Dong, Jing Zhou, Yijie Wu, Zhaofeng Gao, Weiwei Li, Zhengwei Song · 2025 · Frontiers in Cell and Developmental Biology
  36. Combination of tumor organoids with advanced technologies: A powerful platform for tumor evolution and treatment response (Review)
    Ying Hua Wu, Fan Zhang, Furong Du, Juan Huang, Shuqing Wei · 2025 · Molecular Medicine Reports
  37. Using organoid models to predict chemotherapy efficacy: the future of precision oncology?
    Steven Donald Forsythe, Tracey Pu, Aleksander Skardal · 2019 · Expert Review of Precision Medicine and Drug Development
  38. Diagnosing pancreatic ductal adenocarcinoma using plasma extracellular vesicle RNA profiles
    Adam Enver Frampton, Elisa Giovannetti · 2019 · Gut
  39. Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation
    Mounira Chalabi‐Dchar, Elisabeth Cruz, Hichem C. Mertani, Jean‐Jacques Diaz, José Courty, Ilaria Cascone, Philippe Bouvet · 2021 · Cancers
  40. Organoids
    Bernat Navarro-Serer, Laura DeLong Wood · 2022 · Pancreas
  41. Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
    Zhian Xiu, Qian Yang, Fusheng Xie, Feng Han, Weiwei He, Weifang Liao · 2024 · Journal of Tissue Engineering
  42. Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit
    Ilya S. Senatorov, Joel Bowman, Keith H. Jansson, Aian Neil Alilin, Brian J. Capaldo, Ross G. Lake, Morgan Riba, Yasmine C. Abbey, Crystal G. McKnight, Xiaohu Zhang et al. · 2024 · Cell Reports Medicine
  43. Patient-Derived Organoids: Promises, Hurdles and Potential Clinical Applications
    Somaieh Hedayat, Nicola Valeri · 2020 · Clinical Oncology
  44. A Tumor‐Organoid‐Based Precision Medicine Platform for the Prediction of Drug Sensitivity of Colorectal Cancer
    Xingyue Wang, Xiaohuan Lu, Bo Cai, Xiaoqiong Li, Danyi Zou, Shijun Lei, Luming Xu, Guobin Wang, Lin Wang, Zheng Wang · 2022 · Advanced Therapeutics
  45. Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
    Jesús Frutos Dıáz-Alejo, Simon April-Monn, Marina Cihova, Verona Buociková, Jorge Villalón López, Maria Urbanova, Carmen G. Lechuga, Miroslav Tomáš, Peter Dubovan, Bárbara Luna Sánchez et al. · 2023 · Journal of Visualized Experiments
  46. Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target
    Xiaoxiao Du, Kuifeng He, Yingying Huang, Zhenzhen Xu, Mei Kong, Jing Zhang, Jiang Cao, Lisong Teng · 2020 · International Journal of Oncology
  47. Novel co-culture strategies of tumor organoids with autologous T-cells reveal clinically relevant combinations of immune-checkpoint and targeted therapies
    Enrique Podaza, Jared A. Capuano, Majd Al Assaad, Hui–Hsuan Kuo, Geoffrey J. Markowitz, Adriana Irizarry, Hiranmayi Ravichandran, Sarah E. Ackermann, Troy Kane, Jyothi Manohar et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects
    Ruiyang Li, Yuezhou Wu, Zhu'anzhen Zheng, Fengjin Zhou, Ke Xu, Jiacan Su · 2026 · MedComm
  49. Familial Pancreatic Cancer Research: Bridging Gaps in Basic Research and Clinical Application
    Suyakarn Archasappawat, Fatimah Al-Musawi, Peinan Liu, Eunjung Lee, Chang‐Il Hwang · 2024 · Biomolecules
  50. Pancreatic 3D Organoids and Microfluidic Systems—Applicability and Utilization in Surgery: A Literature Review
    Vidas Petrauskas, Ryte Damaseviciute, Aistė Gulla · 2025 · Medicina
  51. Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypes
    Natalie Landon‐Brace, Simon Latour, Brendan T. Innes, Michelle Nurse, Jose L. Cadavid, Ileana L. Co, Cassidy M Tan, Ferris Nowlan, Sibyl Drissler, Faiyaz Notta et al. · 2025 · Scientific Reports
  52. Head and neck tumor organoid grown under simplified media conditions model tumor biology and chemoradiation responses
    Weilin Li, Michiya Nishino, Eric R. Reed, Dipikaa Akshinthala, Hamdan Ahmed Pasha, Erik S. Anderson, Ling Huang, Hannah Hebestreit, Stefano Monti, Ernest Gomez et al. · 2025 · Scientific Reports
  53. Homologous Repair‐Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy
    Alica K. Beutel, Christopher J. Halbrook, Menar Ekizce, Jessica Lindenmayer, Élodie Roger, Sabrina E. Calderon, Thomas Theodor Werner Seufferlein, Alexander Kleger, Johann Gout, Lukas Perkhofer · 2025 · United European Gastroenterology Journal
  54. Functional Precision in Pancreatic Cancer: Redefining Biomarkers with Patient-Derived Organoids
    Claire Alexandra Zhen Chew, Cheng Mun Wun, Y.F. Lee, Cheng Ean Chee, Khek Yu Ho, Glenn Kunnath Bonney · 2025 · International Journal of Molecular Sciences
  55. Emerging Diagnostic Indications for Endoscopic Ultrasound
    Michael B. Wallace, Shounak Majumder, Peter Störz, Jeanin Elise van Hooft · 2026 · Gastroenterology
  56. Single-cell spatial transcriptional profiling of pancreatic ductal adenocarcinoma uncovers key immune-modulating and pro-metastatic mechanisms
    Jing Zhou, Guodong Shi, Shangnan Dai, Shitao Wu, Fangze Qian, Zehao Wu, Jiaxuan Zhang, Yefan Yang, Bin Xiao, Zipeng Lu et al. · 2026 · Cancer Letters
  57. Preclinical models derived from endoscopic ultrasound-guided tissue acquisition for individualized treatment of pancreatic ductal adenocarcinoma
    Ting Tong, Chao Zhang, Jingbo Li, Minzi Deng, Xiaoyan Wang · 2023 · Frontiers in Medicine
  58. Spatial Alignment of Organoids Tracking Subclonal Chemotherapy Resistance in Pancreatic and Ampullary Cancer
    Md Shahadat Hossan, Ethan Samuel Lin, Eleanor Riedl, Austin Stram, Eric Mehlhaff, Luke Koeppel, Jamie Warner, Inem Uko, Lori Mankowski Gettle, Sam Joseph Lubner et al. · 2023 · Bioengineering
  59. Advances in Systemic Therapy in Pancreatic Cancer
    Kenneth H. Yu · 2024 · Hematology/Oncology Clinics of North America
  60. Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back
    Eloise G. Lloyd, Joaquín Araos Henríquez, Giulia Biffi · 2024 · Disease Models & Mechanisms
  61. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
    Jingyu An, Roma Kurilov, Teresa Peccerella, Frank Bergmann, Mouad Edderkaoui, Adrian Lim, Xu Zhou, Katrin Pfütze, Angela Schulz, Stephan Wolf et al. · 2024 · Translational Oncology
  62. Quercetin Promote the Chemosensitivity in Organoids Derived from Patients with Breast Cancer
    Shengwen Meng, Yifan Cao, Lei Lu, Xuanhe Li, Siyu Sun, Fangqian Jiang, Jianfei Lu, Dongwei Fan, Xinxin Han, Tingjing Yao · 2024 · Breast Cancer Targets and Therapy
  63. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience
    Cinthya Yabar Lowder, Teena Dhir, Austin B. Goetz, Henry L. Thomsett, Joseph Bender, Talar Tatarian, Subha Madhavan, Emanuel F. Petricoin, Edik Matthew Blais, Harish Lavu et al. · 2020 · Surgical Oncology
  64. Current Status and Perspectives of Patient-Derived Models for Ewing’s Sarcoma
    Tadashi Kondo · 2020 · Cancers
  65. Organoids and epithelial ovarian cancer ‑ a future tool for personalized treatment decisions?
    Yagmur Sisman, Tine Henrichsen Schnack, Estrid Vilma Solyom Høgdall, Claus Kim Høgdall · 2021 · Molecular and Clinical Oncology
  66. Creation and Development of Patient-Derived Organoids for Therapeutic Screening in Solid Cancer
    William Harrison Hicks, Cylaina E. Bird, Lauren C. Gattie, Mohamad El Shami, Jeffrey Isaac Traylor, Diana D. Shi, Samuel K. McBrayer, Kalil G. Abdullah · 2022 · Current Stem Cell Reports
  67. Beyond the snapshot: optimizing prognostication and prediction by moving from fixed to functional multidimensional cancer pathology
    Claire J.H. Kramer, Maaike P.G. Vreeswijk, Bram Thijssen, Tjalling Bosse, Jelle Wesseling · 2022 · The Journal of Pathology
  68. Les organoïdes derives de tumeurs (ou tumoroïdes), des outils de choix pour la medecine de precision en oncologie
    Marion Perréard, Romane Florent, Lucie Thorel, Audrey Vincent, Louis‐Bastien Weiswald, Laurent Poulain · 2022 · médecine/sciences
  69. Targeting homologous recombination addicted tumors: challenges and opportunities
    Talia Golan, Jonathan Robert Brody · 2020 · Annals of Pancreatic Cancer
  70. Breast cancer immunotherapy: Current biomarkers and the potential of in vitro assays
    Melissa C. Skala, José María Ayuso, Mark E. Burkard, Dustin A. Deming · 2021 · Current Opinion in Biomedical Engineering
  71. The autophagy initiating kinase ULK1 is required for pancreatic cancer cell growth and survival
    Sonja N. Brun, Gencer Sancar, Jan C. Lumibao, Allison S. Limpert, Huiyu Ren, Angela Ianniciello, Hervé Tiriac, Michael Downes, Dannielle D. Engle, Ronald M. Evans et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  72. A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoids
    Oronza Antonietta Botrugno, Elena Bianchi, Jolanda M. Bruno, Giovanni F.M. Gallo, Claudia Felici, Eduardo Sommella, Paola De Stefano, Valentina Giansanti, Valeria Rossella, Fabrizio Merciai et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens
    Meijuan Wang, Chao Gao, Xin S. Huang, Min Wang, Shuai Zhang, Xiaopei Gao, Changqing Zhong, Lianyong Li · 2025 · Cancers
  74. WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2
    Jordan Wilson, Jiayi Zhu, Vanesa Vinciauskaite, Eloise G. Lloyd, Simon C.C. Lam, Alexandra Hart, Chen Gang Goh, Fadia Bou-Dagher, Hlib Razumkov, Lena Kobel et al. · 2025 · Nature Communications
  75. Three-Dimensional Culture Systems in Neuroblastoma Research
    Piotr Jung, Adam J. Wolpaw · 2025 · Organoids
  76. Simulating tumor complexity: 3D pancreatic tumor spheroid model for improved drug screening
    Subia Bano, Ankitkumar Patel, Simran Nathwani, Krishnarup Ghoshdastidar, Mukul Jain, Kasinath Viswanathan · 2025 · Human Cell
  77. Cancer Stem Cells Shift Metabolite Acetyl‐Coenzyme A to Abrogate the Differentiation of CD103 + T Cells
    Jiaxin Lei, Huiyan Ji, Jing Guo, Mengdi Liu, Danhua Su, Yiran Zheng, Lin Xu, Qinghua Cao, Tao Ren, Jun Gui et al. · 2025 · Advanced Science
  78. Splice-switching ASOs targeting the AURKA 5′ UTR collapse an SRSF1-AURKA-MYC oncogenic circuit in pancreatic cancer
    Alexander J. Kral, Lu Jia, GeunYoung Sim, Ledong Wan, Yuma Ishigami, Adrian R. Krainer · 2025 · Molecular Cell
  79. Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug
    Laura Antonucci, Kosuke Watari, Yechen Feng, Jingjing Qi, Mandy Zhu, Tingya Wang, Isabella Ng, Emily Vucic, Irene Riahi, Li Huang et al. · 2026 · Proceedings of the National Academy of Sciences
  80. Deconstructing cancer in 3D: models, mechanisms, and personalized solutions
    Zhao Huang, Xirui Duan, Jun Ji, Qu Cai, Ping Jin, Beiqin Yu, Jun Zhang (48506) · 2026 · Molecular Cancer
  81. Can Pancreatic Organoids Help in the Treatment of Pancreatic Cancer?
    Toni T. Seppälä, Richard Andrew Burkhart · 2021 · Advances in Surgery
  82. Bibliometric Analysis of Organoids in Regenerative Medicine-Related Research Worldwide Over Two Decades (2002–2022)
    Jajar Setiawan, Dicky Moch Rizal, Fajar Sofyantoro, Dwi Sendi Priyono, Nur Indah Septriani, Wulan Usfi Mafiroh, Takenori Kotani, Takashi Matozaki, Wahyu Aristyaning Putri · 2024 · Regenerative Medicine
  83. The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent “in-tumour” chemotherapy to pancreatic ductal adenocarcinoma
    Luned M. Badder, James A. Davies, Valérie S. Méniel, Mahulena Marušková, Beatriz Salvador-Barberó, Rebecca J. Bayliss, Toby James Phesse, Catherine Hogan, Alan L. Parker · 2024 · British Journal of Cancer
  84. TRx0237 induces apoptosis and enhances anti-PD-1 immunotherapeutic efficacy in anaplastic thyroid Cancer
    Qingyang Ning, Jiaye Liu, Xixi Zhu, Shijing Liu, Quanqing Zou, Zhihui Li, Zhihui Li · 2025 · International Immunopharmacology
  85. Case Report: Personalized treatment in stage IV breast cancer using the patient-derived organoids
    Ying Wu, Hao Pi, Xiaowu He, Yuan Sheng · 2025 · Frontiers in Oncology
  86. Tumor organoid and tumor-on-a-chip equipped next generation precision medicine
    Wentao Zhao, Zilin Zhang, Shihui Xu, Xuan Sun, Yan Wang, Jiexian Ye, Xinling Wang, Zhongze Gu, Zaozao Chen · 2025 · Biofabrication
  87. New approach methodologies in Crohn’s disease link molecular disease subtypes to clinical outcomes
    Harrison M. Penrose, Saptarshi Sinha, Courtney Tindle, Kameron M. Zablan, Helen N. Le, Jennifer Neill, Pradipta Ghosh, Brigid Sweeney Boland · 2026 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  88. Stories of drug repurposing for pancreatic cancer treatment—Past, present, and future
    Matthias Ilmer, Maximilian Weniger, Hanno Nieß, Yang Feng Wu, Chun Zhang, Christoph Benedikt Westphalen, Stephan Krüger, Martin Kurt Angele, Jens Martin Werner, Jan Goesta D’Haese et al. · 2020 · Elsevier eBooks
  89. The Burn Behind the Bullet: Understanding Black Mothers’ Experiences After Losing a Child to Gun Violence in Washington, DC-Baltimore City Metropolitan Region
    Denzell Brown · 2021 · Georgetown Scientific Research Journal
  90. Ultrasound-guided fine-needle aspiration/biopsy-based pancreatic organoids establishment: an alternative model for basic and preclinical research
    Sheng Chen, Min Wang, Lei Liu, Guodong Wang, Lei Wang, Changqing Zhong, Chao Gao, Wei Dong Wu, Lianyong Li · 2022 · Gastroenterology report
  91. Precision Oncology in Hepatopancreatobiliary Cancer Surgery
    Timothy Eric Newhook, Susan Tsai, Funda Meric‐Bernstam · 2026 · Hematology/Oncology Clinics of North America
  92. Comprehensive bibliometric analysis and perspectives on therapies targeting colon cancer stem cells over a 40-year period
    Şeyda Berk · 2025 · Regenerative Therapy
  93. Clinical Scenarios Emerging from Combined Immunophenotypic, Molecular and Morphologic Analysis of Pancreatic Cancer: The Good, the Bad and the Ugly Scenario
    Eva Karamitopoulou, Beat Gloor · 2019 · Cancers
  94. Human Gastrointestinal Organoid Models for Studying Microbial Disease and Cancer
    Jayati L. Chakrabarti, Martha Dua-Awereh, Loryn L. Holokai, Yana L. Zavros · 2020 · Current topics in microbiology and immunology
  95. Environment Influences Tumor Progression and Transcriptional Subtype in a New Model of Pancreatic Cancer
    Karen A. Pickering, Jennifer P. Morton · 2020 · Cancer Discovery
  96. A contemporary evidence basis for neoadjuvant chemotherapy in upfront resectable pancreatic adenocarcinoma: a systematic review of the literature
    David P. Stonko, Jin Peng He, Lei Zheng, Alex B. Blair · 2020 · Journal of Pancreatology
  97. FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: An Observational Study
    Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido et al. · 2022 · Future Oncology
  98. Generation of Human Kidney Tubuloids from Tissue and Urine
    Camilla Calandrini, Jarno Drost · 2021 · Journal of Visualized Experiments
  99. Patient-derived organoids: Are PDOs the new PDX?
    Tríona Ní Chonghaile · 2018 · Science Translational Medicine
  100. Cancer modeling in colorectal organoids reveals intrinsic differences between oncogenic RAS and BRAF variants
    Jasmin B. Post, Nizar Hami, Jeroen O. Lohuis, Marieke van de Ven, Renske de Korte‐Grimmerink, Christina Stangl, Ellen Stelloo, Ingrid Verlaan-Klink, Jacco van Rheenen, Hugo J.G. Snippert · 2019 · bioRxiv (Cold Spring Harbor Laboratory)